AL
Andrew Lin
Associate Attending Neurologist · New York Presbyterian Hospital
Credentials: · · · ·
History
Research
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
Blood · 2019 · 201 citations
Clinical Cancer Research · 2019 · Co-first of 43 authors · Corresponding · 129 citations
Journal of Clinical Oncology · 2022 · 129 citations
- VT
21 papers
- RY
14 papers
- EG
13 papers
- MR
12 papers
11 papers
10 papers
- IM
10 papers
- LD
10 papers
